Open AccessIn Reply to the Discovery Trial Report Evaluating the Potential Benefit of Hydroxychloroquine, Lopinavir and Ritonavir with and Without Interferon Β-1a in Hospitalized Covid-19 Patients
Author(s) -
Valère Lounnas,
Xavier Azalbert,
Christian Perronne
Publication year - 2021
Publication title -
archives of microbiology and immunology
Language(s) - English
Resource type - Journals
ISSN - 2572-9365
DOI - 10.26502/ami.93650064
Subject(s) - lopinavir , hydroxychloroquine , lopinavir/ritonavir , ritonavir , covid-19 , medicine , virology , interferon , intensive care medicine , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom